{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:01:53Z","timestamp":1788354113459,"version":"build-2803163510"},"reference-count":28,"publisher":"BMJ","issue":"Suppl 1","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"unspecified","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Patient-Centered Outcomes Research Trust Fund","award":["Interagency Agreement #750119PE060048"],"award-info":[{"award-number":["Interagency Agreement #750119PE060048"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Surg Interv Health Technologies"],"accepted":{"date-parts":[[2022,5,13]]},"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>The accumulation of data through a prospective, multicenter coordinated registry network (CRN) is a robust and cost-effective way to gather real-world evidence on the performance of uterine fibroids treatment technologies for device-based and intervention-based studies. To develop the CRN, a group of uterine fibroids experts, consisting of representatives from professional societies, the US Food and Drug Administration, academia, industry, and the patient community, was convened to discuss the role and feasibility of the CRN and to identify the core data elements needed to assess uterine fibroid treatment technologies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>A Delphi method approach was employed to achieve consensus on a core minimum data set for the CRN. A series of surveys were sent to the panel and answered by each expert anonymously and individually. Results from the surveys were collected, collated, and analyzed by a study design team from Weill Cornell Medicine. Questions for the next round were based on the analysis process and discussed with group members via a conference call. This process was repeated twice over a 3-month time period until consensus was achieved.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty-nine experts participated in the Delphi surveys, which began with an initial list of 200 data elements. The working group reached final consensus on 97 data elements capturing patient medical history, imaging data, procedure-related data, post-procedure data, and long-term follow-up data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The CRN successfully convened an expert panel on uterine fibroids treatment technologies and used the Delphi method to produce a consensus-based core set of data elements. These identified data elements include important outcomes related to efficacy and safety and thus, influence patient, provider, and regulatory decision-making about treatments for uterine fibroids. Finally, the core data elements provide the foundation of the infrastructure needed for the CRN that will allow for the comparative study of uterine fibroid treatment devices and technologies.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjsit-2021-000094","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T17:01:44Z","timestamp":1668445304000},"page":"e000094","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Development of a core minimum data set to advance real-world evidence generation for uterine fibroids treatment technologies"],"prefix":"10.1136","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2841-9183","authenticated-orcid":false,"given":"Courtney E","family":"Baird","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Jacoby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2042-2174","authenticated-orcid":false,"given":"Laura Elisabeth","family":"Gressler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sateria","family":"Venable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angie","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3882-9765","authenticated-orcid":false,"given":"Art","family":"Sedrakyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danica","family":"Marinac-Dabic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,11,14]]},"reference":[{"key":"2024051514355767000_4.Suppl_1.e000094.1","unstructured":"U.S. Department of Health and Human Services Office on Women\u2019s Health. Uterine Fibroids. Available: https:\/\/www.womenshealth.gov\/a-z-topics\/uterine-fibroids [Accessed 1 Jul 2020]."},{"key":"2024051514355767000_4.Suppl_1.e000094.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1701-2163(15)30338-8"},{"key":"2024051514355767000_4.Suppl_1.e000094.3","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmw023"},{"key":"2024051514355767000_4.Suppl_1.e000094.4","unstructured":"Hartmann KE , Fonnesbeck C , Surawicz T . Management of uterine fibroids. Rockville (MD), 2017."},{"key":"2024051514355767000_4.Suppl_1.e000094.5","doi-asserted-by":"crossref","first-page":"319.e1","DOI":"10.1016\/j.ajog.2013.07.017","article-title":"The impact of uterine leiomyomas: a national survey of affected women","volume":"209","author":"Borah","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"2024051514355767000_4.Suppl_1.e000094.6","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2013.4334"},{"key":"2024051514355767000_4.Suppl_1.e000094.7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.11036"},{"key":"2024051514355767000_4.Suppl_1.e000094.8","unstructured":"Krucoff M , Normand S , Edwards F . Recommendations for a national medical device evaluation system: strategically coordinated registry networks to bridge clinical care and research. Silver Spring, MD: US Food Drug Administration, ed, 2015: 1\u2013141."},{"key":"2024051514355767000_4.Suppl_1.e000094.9","unstructured":"Medical Device Epidemiology Network (MDEpiNet) . National women\u2019s health initiative think-tank 2017. Available: http:\/\/mdepinet.org\/event\/national-womens-health-initiative-think-tank\/ [Accessed 31 Mar 2020]."},{"key":"2024051514355767000_4.Suppl_1.e000094.10","unstructured":"Medical Device Epidemiology Network (MDEpiNet) . Patient partners 2020. Available: https:\/\/mdepinet.org\/mdepinet-patient-partners\/ [Accessed 31 Mar 2020]."},{"key":"2024051514355767000_4.Suppl_1.e000094.11","unstructured":"Brown BB . Delphi process: a methodology used for the elicitation of opinions of experts, 1968. Available: https:\/\/www.rand.org\/content\/dam\/rand\/pubs\/papers\/2006\/P3925.pdf"},{"key":"2024051514355767000_4.Suppl_1.e000094.12","unstructured":"Hsu CaS BA . The Delphi technique: making sense of consensus. Practical Assessment, Research & Evaluation 2007;12."},{"key":"2024051514355767000_4.Suppl_1.e000094.13","unstructured":"Marinac-Dabic D , Aryal S , Azarbaijani Y , et al . The Women\u2019s Health Technologies Coordinated Registry Network (WHT-CRN): U.S. Food and Drug Administration, 2020. Available: https:\/\/9a8ad4b9-d27b-46ff-9aa0-f3457074f526.filesusr.com\/ugd\/361e0e_bf040bd8f23b48a182394b0d6ce9eb04.pdf"},{"key":"2024051514355767000_4.Suppl_1.e000094.14","unstructured":"Yousuf M . Using experts\u2019 opinions through Delphi technique. Practical Assessment, Research & Evaluation 2007;12."},{"key":"2024051514355767000_4.Suppl_1.e000094.15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjsit-2021-000123","article-title":"Advancing the real-world evidence for medical devices through coordinated registry networks","volume":"4","author":"Sedrakyan","year":"2022","journal-title":"BMJ Surgery, Interventions, & Health Technologies"},{"key":"2024051514355767000_4.Suppl_1.e000094.16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjsit-2020-000075","article-title":"Building blocks for long-acting and permanent contraceptives coordinated registry network","volume":"4","author":"Baird","year":"2022","journal-title":"BMJ Surgery, Interventions, and Health Technologies"},{"key":"2024051514355767000_4.Suppl_1.e000094.17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjsit-2020-000076","article-title":"Development of a coordinated registry network for pelvic organ prolapse technologies","volume":"4","author":"Baird","year":"2022","journal-title":"BMJ Surgery, Interventions, and Health Technologies"},{"key":"2024051514355767000_4.Suppl_1.e000094.18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ejvs.2018.04.006","article-title":"International Consortium of vascular registries consensus recommendations for peripheral revascularisation registry data collection","volume":"56","author":"Behrendt","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2024051514355767000_4.Suppl_1.e000094.19","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.juro.2017.12.058","article-title":"Development of a nationally representative coordinated registry network for prostate ablation technologies","volume":"199","author":"Golan","year":"2018","journal-title":"J Urol"},{"key":"2024051514355767000_4.Suppl_1.e000094.20","doi-asserted-by":"crossref","first-page":"95.e1","DOI":"10.1016\/j.ajog.2018.05.004","article-title":"The comparing options for management: patient-centered results for uterine fibroids (COMPARE-UF) registry: rationale and design","volume":"219","author":"Stewart","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"2024051514355767000_4.Suppl_1.e000094.21","unstructured":"Duke Clinical Research Institute . Registry data standards Durham. NC: Duke University and Duke University Health System, 2020. https:\/\/dcri.org\/registry-data-standards\/"},{"key":"2024051514355767000_4.Suppl_1.e000094.22","unstructured":"HHS Assistant Secretary for Planning and Evaluation (ASPE) . Developing a strategically Coordinated Registry Network (CRN) for women\u2019s health technology Washington, DC, 2018. Available: https:\/\/aspe.hhs.gov\/developing-strategically-coordinated-registry-network-crn-womens-health-technology [Accessed 31 Mar 2020]."},{"key":"2024051514355767000_4.Suppl_1.e000094.23","unstructured":"US National Library of Medicine . Value set authority center Bethesda, MD2020, 2020. Available: https:\/\/vsac.nlm.nih.gov\/ [Accessed 31 Mar 2020]."},{"key":"2024051514355767000_4.Suppl_1.e000094.24","unstructured":"HL7 International - Biomedical Research and Regulation Work Group . Women\u2019s Health Technologies (WHT) Coordinated Registry Network (CRN) FHIR Implementation Guide 2019. Available: http:\/\/hl7.org\/fhir\/us\/womens-health-registries\/2019May\/ [Accessed 27 Mar 2019]."},{"key":"2024051514355767000_4.Suppl_1.e000094.25","unstructured":"PCORnet: the National patient-centered clinical research network. Available: https:\/\/pcornet.org"},{"key":"2024051514355767000_4.Suppl_1.e000094.26","unstructured":"Developing a Strategically Coordinated Registry Network (CRN) for Women\u2019s Health Technologies Final Report: The Office of the National Coordinator for Health Information Technology, 2020. Available: https:\/\/www.healthit.gov\/sites\/default\/files\/page\/2020-06\/Strategically-CRN-for-Womens-Health-Technologies.pdf"},{"key":"2024051514355767000_4.Suppl_1.e000094.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(01)01702-1"},{"key":"2024051514355767000_4.Suppl_1.e000094.28","unstructured":"US Food Drug Administration . CDRH strategic priorities and updates silver spring, MD, 2018. Available: https:\/\/www.fda.gov\/about-fda\/center-devices-and-radiological-health\/cdrh-strategic-priorities-and-updates2018"}],"container-title":["BMJ Surgery, Interventions, &amp; Health Technologies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjsit-2021-000094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T21:54:07Z","timestamp":1715810047000},"score":1,"resource":{"primary":{"URL":"https:\/\/sit.bmj.com\/lookup\/doi\/10.1136\/bmjsit-2021-000094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":28,"journal-issue":{"issue":"Suppl 1","published-online":{"date-parts":[[2022,11,14]]},"published-print":{"date-parts":[[2022,11]]}},"alternative-id":["10.1136\/bmjsit-2021-000094"],"URL":"https:\/\/doi.org\/10.1136\/bmjsit-2021-000094","relation":{},"ISSN":["2631-4940"],"issn-type":[{"value":"2631-4940","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}